RAF inhibitors and their uses
US7501430B2 · kind B2 · utility
9Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2007 |
| Grant date | Mar 10, 2009 |
| Priority date | — |
| Expiry date | Apr 16, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides imidazooxazole and imidazothiazole compounds and their synthesis. The compounds of the present invention are capable of inhibiting the activity of RAF kinase, such as B-RAFV600E. The compounds are useful for the treatment of cell proliferative disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.